176 related articles for article (PubMed ID: 8095831)
1. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.
Raue F; Kotzerke J; Reinwein D; Schröder S; Röher HD; Deckart H; Höfer R; Ritter M; Seif F; Buhr H
Clin Investig; 1993 Jan; 71(1):7-12. PubMed ID: 8095831
[TBL] [Abstract][Full Text] [Related]
2. German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2.
Raue F
Langenbecks Arch Surg; 1998 Oct; 383(5):334-6. PubMed ID: 9860226
[TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy.
Samaan NA; Schultz PN; Hickey RC
J Clin Endocrinol Metab; 1988 Oct; 67(4):801-5. PubMed ID: 2901430
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR
Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843
[TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
Modigliani E; Cohen R; Campos JM; Conte-Devolx B; Maes B; Boneu A; Schlumberger M; Bigorgne JC; Dumontier P; Leclerc L; Corcuff B; Guilhem I
Clin Endocrinol (Oxf); 1998 Mar; 48(3):265-73. PubMed ID: 9578814
[TBL] [Abstract][Full Text] [Related]
7. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.
Girelli ME; Nacamulli D; Pelizzo MR; De Vido D; Mian C; Piccolo M; Busnardo B
Thyroid; 1998 Jun; 8(6):517-23. PubMed ID: 9669290
[TBL] [Abstract][Full Text] [Related]
8. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ
J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group.
Bergholm U; Adami HO; Bergström R; Bäckdahl M; Akerström G
Acta Chir Scand; 1990 Jan; 156(1):37-46. PubMed ID: 2321439
[TBL] [Abstract][Full Text] [Related]
10. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy.
Duh QY; Sancho JJ; Greenspan FS; Hunt TK; Galante M; deLorimier AA; Conte FA; Clark OH
Arch Surg; 1989 Oct; 124(10):1206-10. PubMed ID: 2802985
[TBL] [Abstract][Full Text] [Related]
12. Demographic, clinical, and genetic characteristics of patients with medullary thyroid cancer in the past 16 years in Castilla-La Mancha.
Louhibi L; Marco A; Pinés PJ; Padillo JC; Gómez I; Valero MA; Alramadán M; Herranz S; Aguirre M; Hernández A
Endocrinol Nutr; 2014 Oct; 61(8):398-403. PubMed ID: 24794695
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma].
Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R
Dtsch Med Wochenschr; 1993 Jan; 118(3):49-52. PubMed ID: 8425457
[TBL] [Abstract][Full Text] [Related]
14. Family screening in medullary thyroid carcinoma presenting without a family history.
Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment and prognosis analysis on medullary thyroid carcinoma].
Zhang ZX; Li ZJ; Tang PZ; Xu ZG; Zhang ZM; An CM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):209-13. PubMed ID: 21575412
[TBL] [Abstract][Full Text] [Related]
16. Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm.
Kakudo K; Carney JA; Sizemore GW
Cancer; 1985 Jun; 55(12):2818-21. PubMed ID: 2859923
[TBL] [Abstract][Full Text] [Related]
17. Familial thyroid cancer.
Alsanea O; Clark OH
Curr Opin Oncol; 2001 Jan; 13(1):44-51. PubMed ID: 11148685
[TBL] [Abstract][Full Text] [Related]
18. Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.
Pinto AE; Silva GL; Henrique R; Menezes FD; Teixeira MR; Leite V; Cavaco BM
Eur J Endocrinol; 2014 Feb; 170(2):321-7. PubMed ID: 24272198
[TBL] [Abstract][Full Text] [Related]
19. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
20. Familial medullary thyroid cancer: clinical aspects and prognosis.
Hyer SL; Newbold K; Harmer C
Eur J Surg Oncol; 2005 May; 31(4):415-9. PubMed ID: 15837050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
